At the American Kratom Association, we understand that our most effective advocates are you: American Kratom Warriors!

We want to make sure that you are equipped with the latest and most relevant information when you go to speak with your legislators. So we have created a toolkit of documents for you to be able to download, study and share. 

AKA Advocacy Toolkit:

Comprehensive AKA Toolkit PDF

Making a First Impression

Webinar Video on AKA Advocacy Toolkit

- AKA Kratom Fact Sheet
- The Kratom Consumer Protection Act Model Legislation
- June 2018 study by Hemby, et. al., showing there is not addiction liability of mitragynine or 7-hydroxymitragynine at the levels found in the natural kratom plant
- 2018 study by Yue et. al., (a National Institute on Drug Abuse – NIDA) affirming the same result of the Hemby study
- Letter of Scientists to the U.S. Congress opposing the FDA recommendation on scheduling of kratom – DEA has not acted on the recommendation that was filed in October 2017
- Dr. Jane Babin Report on FDA Failing to Follow the Science on Kratom, August 2018 that shows the FDA mistakes on both the safety data and the addiction data
- Response from experts to CDC Report